Anti-craving Property of Chlorpromazine in Pentazocine addiction among sickle cell disease patients: A Case Series
DOI:
https://doi.org/10.38029/babcockuniv.med.j..v6i2.182Keywords:
Sickle cell disease , Dependence, Pentazocine, Chlorpromazine, Case seriesAbstract
Background: Opioids are useful in the management of vaso-occlusive crisis among Sickle Cell Disease patients; however, there is a need to search for drugs that can ameliorate the withdrawal symptoms without causing further dependence.
Case presentations: Three patients living with Sickle cell disease abusing Pentazocine were managed with Tab Chlorpromazine 100mg twice daily for three weeks and had a significant reduction in the level of craving and also experienced improved sleep. Chlorpromazine demonstrates a high affinity for dopamine (DA) receptors and acts as a receptor antagonist by inhibiting adenylate cyclase activity.
Conclusion: Chlorpromazine was found to be useful in the management of cravings associated with Pentazocine addiction.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Falade J, Osho PO, Ajayi AA, Ogubgbemi AO, Dare RF, Akinnuoye AA, Sajo S

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
